Cargando…
A plasmatic score using a miRNA signature and CXCL-10 for accurate prediction and diagnosis of liver allograft rejection
INTRODUCTION: The use of noninvasive biomarkers may avoid the need for liver biopsy (LB) and could guide immunosuppression adjustment in liver transplantation (LT). The aims of this study were: to confirm the predictive and diagnostic capacity of plasmatic expression of miR-155-5p, miR-181a-5p, miR-...
Autores principales: | Millán, Olga, Ruiz, Pablo, Julian, Judit, Lizana, Ana, Fundora, Yiliam, Crespo, Gonzalo, Colmenero, Jordi, Navasa, Miquel, Brunet, Mercè |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265684/ https://www.ncbi.nlm.nih.gov/pubmed/37325660 http://dx.doi.org/10.3389/fimmu.2023.1196882 |
Ejemplares similares
-
Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients
por: Millán, Olga, et al.
Publicado: (2019) -
Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection
por: Karason, Kristjan, et al.
Publicado: (2006) -
The presence and outcome of biliary sphincter disorders in liver-transplant recipients according to the Rome IV classification
por: Fernandez-Simon, Alejandro, et al.
Publicado: (2021) -
Association between CXCL9/10 polymorphisms and acute rejection of liver allograft
por: Ostojic, Ana, et al.
Publicado: (2019) -
Active Smoking Before Liver Transplantation in Patients with Alcohol Use Disorder: Risk Factors and Outcomes
por: López-Lazcano, Ana Isabel, et al.
Publicado: (2020)